Long-term use of stomach acid reducers like omeprazole or ranitidine carries distinct safety profiles
Long-term utilization of stomach acid reducers such as proton pump inhibitors carries well-documented safety concerns and distinct adverse event profiles when used beyond recommended durations.
The claim is specific, empirical, and contestable regarding the safety profile of long-term stomach acid reducer use. Retrieved papers such as [0] and [3] explicitly detail the broad spectrum of harms and safety considerations tied to long-term PPI usage, while others discuss risk awareness and prescribing practices. No papers refute the core premise that prolonged acid reducer use carries distinct safety considerations.
Mohamed Ben-Eltriki, Manik Chhabra, Alan Cassels, James M. Wright. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?. 2024. https://doi.org/10.2174/1574886318666230726124540
This study outlines a broad spectrum of documented adverse events associated with the prolonged use of proton pump inhibitors, establishing distinct safety profiles.
See more details
Sawaied IO, Samson AO, Golan E. Patients' perception of proton pump inhibitors use and their risks.. 2026. https://doi.org/10.5306/wjco.v17.i1.113463
This study evaluates patient perception and clinical outcomes regarding long-term PPI therapy and its varied potential adverse effects.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt